Technology area: Biotechnology & Pharmaceuticals
19 pending office actions • 17 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
King's College London has 20 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 18 distinct examiners across 17 distinct art units, indicating that the portfolio is distributed across multiple examination assignments rather than concentrated in one technical lane.
AULAKH, CHARANJIT is the busiest examiner with 2 pending matters. The limited concentration at the busiest examiner suggests that prosecution planning should account for varied examiner practices. Counsel may benefit from matter-specific review of claim scope, written-description support, and response strategy across the separate assignments.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (21%) |
| §103 only | 7 (37%) |
| Double-patenting + other | 2 (11%) |
| Multi-statute (no §101) | 6 (32%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.4% |
| FLORES, ROBERTO W | 1 | 49.8% | +14.0% |
| HARRISON, MICHAEL A | 1 | 89.0% | +2.5% |
| ROBINSON, NICHOLAS A | 1 | 48.4% | +55.0% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 63.9% | +18.1% |
| PEARSON, AMANDA HYEONWOO | 1 | 63.4% | +36.6% |
| PORTILLO, JAIRO H | 1 | 53.4% | +30.7% |
| SAUNDERS, MATTHEW P | 1 | 46.9% | +38.4% |
| TINSLEY, BRENDAN THOMAS | 1 | 60.4% | +74.3% |
| CUNNINGCHEN, KATHLEEN MARY | 1 | 62.5% | +60.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18020010 | LITHIATED SILICON | LI, JUN | 85d overdue |
| 18579582 | Seizure Forecasting in Subsutaneous Electroencephalography Data Using Machine Learning | PORTILLO, JAIRO H | 46d overdue |
| 17767859 | ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF | DABKOWSKI, ERINNE R | 2d overdue |
| 18288236 | TIP FOR A VIBRATING SCALER AND A VIBRATING SCALER | SAUNDERS, MATTHEW P | 9d |
| 18279815 | PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORS | COUGHLIN, MATTHEW P | 14d |
| 18448811 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | VIVLEMORE, TRACY ANN | 70d |
| 19047879 | METHOD FOR RETROSPECTIVELY CALIBRATING AN EXTERNAL MOTION SIGNAL ACQUIRED IN PARALLEL TO AN MRI EXAMINATION | HARRISON, MICHAEL A | — |
| 18607846 | MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION | POLIAKOVA-GEORGAN, EKATERINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579582 | Seizure Forecasting in Subsutaneous Electroencephalography Data Using Machine Learning | PORTILLO, JAIRO H | 46d overdue |
| 18288236 | TIP FOR A VIBRATING SCALER AND A VIBRATING SCALER | SAUNDERS, MATTHEW P | 9d |
| 18853081 | BODY PART SUPPORT | ROBINSON, NICHOLAS A | 70d |
| 19470722 | AUTOMATIC GAZE ESTIMATION | FLORES, ROBERTO W | — |
| 18607846 | MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18607527 | COMPUTING SYSTEM FOR PROVIDING A MAPPING OF A PHYSICAL QUANTITY ON A BIOLOGICAL TISSUE AND METHOD THEREOF | PEARSON, AMANDA HYEONWOO | — |
| 18283660 | ISOLATED PRIMARY DERMAL FIBROBLASTS FOR TREATING SKIN CONDITIONS | TINSLEY, BRENDAN THOMAS | — |
| 18551843 | COMPOSITIONS COMPRISING NKG2D, CXCR2, AND DAP10/DAP12 FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | CUNNINGCHEN, KATHLEEN MARY | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1638 | 2 |
| 2621 | 1 |
| 2852 | 1 |
| 3798 | 1 |
| 1637 | 1 |
| 2666 | 1 |
| 3791 | 1 |
| 3772 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19470722 | AUTOMATIC GAZE ESTIMATION | FLORES, ROBERTO W | 2621 | §103 | Non-Final OA | — | Pending | Sep 29, 2025 |
| 19047879 | METHOD FOR RETROSPECTIVELY CALIBRATING AN EXTERNAL MOTION SIGNAL ACQUIRED IN PARALLEL TO AN MRI EXAMINATION | HARRISON, MICHAEL A | 2852 | §101§102 | Non-Final OA | — | Pending | Feb 07, 2025 |
| 18853081 | BODY PART SUPPORT | ROBINSON, NICHOLAS A | 3798 | §103 | Final Rejection | 70d | Pending | Sep 30, 2024 |
| 18607846 | MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §101§112DP | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18607527 | COMPUTING SYSTEM FOR PROVIDING A MAPPING OF A PHYSICAL QUANTITY ON A BIOLOGICAL TISSUE AND METHOD THEREOF | PEARSON, AMANDA HYEONWOO | 2666 | §103 | Final Rejection | — | Pending | Mar 17, 2024 |
| 18579582 | Seizure Forecasting in Subsutaneous Electroencephalography Data Using Machine Learning | PORTILLO, JAIRO H | 3791 | §101§103 | Final Rejection | 46d overdue | Pending | Jan 16, 2024 |
| 18288236 | TIP FOR A VIBRATING SCALER AND A VIBRATING SCALER | SAUNDERS, MATTHEW P | 3772 | §102§103 | Non-Final OA | 9d | Pending | Oct 25, 2023 |
| 18283660 | ISOLATED PRIMARY DERMAL FIBROBLASTS FOR TREATING SKIN CONDITIONS | TINSLEY, BRENDAN THOMAS | 1634 | §103 | Final Rejection | — | Pending | Sep 22, 2023 |
| 18551843 | COMPOSITIONS COMPRISING NKG2D, CXCR2, AND DAP10/DAP12 FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | CUNNINGCHEN, KATHLEEN MARY | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18279815 | PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORS | COUGHLIN, MATTHEW P | 1626 | §102§112 | Final Rejection | 14d | Pending | Aug 31, 2023 |
| 18448807 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | VIVLEMORE, TRACY ANN | 1638 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18448811 | COMPOSITIONS AND METHODS FOR ENHANCING GAMMA DELTA T CELLS IN THE GUT | VIVLEMORE, TRACY ANN | 1638 | §102§112 | Non-Final OA | 70d | Pending | Aug 11, 2023 |
| 18030996 | NANOPARTICLE FOR ANTI-CANCER PEPTIDES AND USES THEREOF | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103§112Other | Non-Final OA | — | Pending | Apr 08, 2023 |
| 18020010 | LITHIATED SILICON | LI, JUN | 1732 | §102§103 | Final Rejection | 85d overdue | Pending | Feb 06, 2023 |
| 18002761 | OXINE-CONTAINING CELL RADIOLABELLING AGENTS | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 89d overdue | Pending | Dec 21, 2022 |
| 17767859 | ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF | DABKOWSKI, ERINNE R | 1654 | §103§112Other | Final Rejection | 2d overdue | Pending | Apr 08, 2022 |
| 17634720 | IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF THE IL-1 SUPERFAMILY | ABBOTT, KODYE LEE | 1634 | §103 | Final Rejection | — | Pending | Feb 11, 2022 |
| 17612074 | Substituted 4-[5-(Benzofuran-2-yl)-1,2,4-Oxadiazol-3-yl]Benzoic Acid Compounds for Use in Therapy for Neuropathic Pain | DAHLIN, HEATHER RAQUEL | 1629 | §103DP | Final Rejection | 12d | Pending | Nov 17, 2021 |
| 17272126 | ENGINEERED REGULATORY T CELL | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Final Rejection | — | Pending | Feb 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKing's College London has 19 pending office actions as of October 2026, spread across 17 art units and 18 examiners.
Tracy Ann Vivlemore has the most, with 2 of King's College London's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
